南方医科大学学报 ›› 2025, Vol. 45 ›› Issue (5): 977-985.doi: 10.12122/j.issn.1673-4254.2025.05.10

• • 上一篇    下一篇

积雪草苷通过抑制NLRP3炎症体介导的细胞焦亡减轻大鼠心肌缺血再灌注损伤

卞芬兰1,3(), 倪诗垚2,3, 赵鹏1,3, 戚毛男星1,3, 唐碧1, 王洪巨1, 康品方1,3(), 刘进军1,3()   

  1. 1.蚌埠医科大学,第一附属医院心血管科,安徽 蚌埠 233000
    2.蚌埠医科大学,耳鼻喉科,安徽 蚌埠 233000
    3.蚌埠医科大学,心脑血管基础与临床重点实验室,安徽 蚌埠 233000
  • 收稿日期:2024-11-18 出版日期:2025-05-20 发布日期:2025-05-23
  • 通讯作者: 康品方,刘进军 E-mail:1174672677@qq.com;kangpinfang.1016@163.com;ljj19740828101@163.com
  • 作者简介:卞芬兰,在读硕士研究生,E-mail: 1174672677@qq.com
  • 基金资助:
    国家自然科学基金(81970313);安徽省自然科学基金(2208085MH192);安徽省高校协同创新项目(GXXT-2020-019);安徽省优秀青年基金(2022AH030141);安徽省优秀创新团队(2022AH010083);蚌埠医学院研究生科研创新计划项目(Byycx24021);安徽省临床转化课题青年项目(202304295107020087)

Asiaticoside alleviates myocardial ischemia-reperfusion injury in rats by inhibiting NLRP3 inflammasome-mediated pyroptosis

Fenlan BIAN1,3(), Shiyao NI2,3, Peng ZHAO1,3, Maonanxing QI1,3, Bi TANG1, Hongju WANG1, Pinfang KANG1,3(), Jinjun LIU1,3()   

  1. 1.Department of Cardiology, First Affiliated Hospital of Bengbu MedicalUniversity, Bengbu 233000, China
    2.Department of Otolaryngology, First Affiliated Hospital of Bengbu MedicalUniversity, Bengbu 233000, China
    3.Key Laboratory of Cardio-Cerebrovascular Foundation and Clinical Sciences of Bengbu MedicalUniversity, Bengbu 233000, China
  • Received:2024-11-18 Online:2025-05-20 Published:2025-05-23
  • Contact: Pinfang KANG, Jinjun LIU E-mail:1174672677@qq.com;kangpinfang.1016@163.com;ljj19740828101@163.com
  • Supported by:
    National Natural Science Foundation of China(81970313)

摘要:

目的 探讨积雪草苷(AS)在保护大鼠心肌缺血再灌注损伤(MIRI)中的保护机制。 方法 将50只SD大鼠随机分为假手术组(sham)、模型组(I/R)、AS处理组。AS处理组在手术前连续2周灌胃,根据给予不同剂量的AS分为低剂量组、中剂量组、高剂量组, 10只/组。检测血清中的乳酸脱氢酶(LDH)、肌酸激酶同工酶(CK-MB)、白介素-18(IL-18)和白介素-1β(IL-1β)浓度,测量各组大鼠心肌梗死和缺血范围,并观察心肌组织的病理变化。使用Western blotting法检测心肌组织中NLRP3、ASC、caspase-1、GSDMD、GSDMD-N、IL-1β和IL-18的蛋白含量。此外,通过缺氧复氧(H/R)实验在H9C2细胞中模拟缺血再灌注损伤,并进行AS预处理。 结果 与sham组相比,I/R组心肌梗死和缺血范围增加,血清中LDH和CK-MB水平升高,心肌组织中NLRP3、ASC、caspase-1、GSDMD、GSDMD-N、IL-1β和IL-18蛋白含量升高(P<0.05)。与I/R组相比,AS处理组的心肌梗死范围、血清LDH和CK-MB水平降低,心肌组织中上述蛋白含量也降低(P<0.05),且AS的保护作用呈剂量依赖性。体外实验显示,H/R处理导致NLRP3、ASC、caspase-1、GSDMD、GSDMD-N、IL-1β和IL-18蛋白表达增加(P<0.05),而AS预处理可减轻H/R损伤(P<0.05)。分子对接结果表明,AS与NLRP3具有良好的结合活性。 结论 积雪草苷可以减轻大鼠心肌再灌注损伤,其机制可能通过抑制NLRP3炎症体介导的细胞焦亡实现。

关键词: 积雪草苷, 心肌缺血再灌注损伤, NLRP3, 细胞焦亡

Abstract:

Objective To study the mechanism mediating the protective effect of asiaticoside (AS) against myocardial ischemia-reperfusion injury (MIRI) in rats. Methods Fifty SD rats were randomized into sham-operated group, MIRI model group and AS treatment group. AS treatment was administered at low, moderate and high doses by daily gavage for 2 weeks before MIRI modeling (n=10). Serum levels of lactate dehydrogenase (LDH), creatine kinase isoenzyme (CK-MB), interleukin-18 (IL-18) and IL-1β, the volume of myocardial infarction and ischemia, and myocardial pathologies of the rats were determined or observed. The protein expression levels of NLRP3, ASC, caspase-1, GSDMD, GSDMD-N, IL-1β and IL-18 in the myocardial tissues were detected using Western blotting. The changes in the expression levels of these proteins were also detected in H9C2 cells with AS pretreatment prior to hypoxia-reoxygenation (H/R) injury. Results The rats models of MIRI exhibited significant myocardial infarction and ischemia with increased serum levels of LDH and CK-MB and myocardial expressions of NLRP3, ASC, caspase-1, GSDMD, GSDMD-N, IL-1β and IL-18. AS pretreatment effectively reduced myocardial infarction volume in the rat models and significantly reduced serum LDH and CK-MB levels and the protein levels in the myocardial tissue in a dose-dependent manner. In the H9C2 cell model of H/R injury, AS pretreatment significantly suppressed the elevation of the protein expressions of NLRP3, ASC, caspase-1, GSDMD, GSDMD-N, IL-1β and IL-18. Molecular docking studies showed that AS had a strong binding affinity with NLRP3. Conclusion Asiaticoside can alleviate MIRI in rats possibly by inhibiting NLRP3 inflammasome-mediated pyroptosis.

Key words: asiaticoside, myocardial ischemia-reperfusion injury, NLRP3, pyroptosis